A detailed history of Sepio Capital, LP transactions in Cerus Corp stock. As of the latest transaction made, Sepio Capital, LP holds 1,147,500 shares of CERS stock, worth $1.97 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,147,500
Previous 1,347,500 14.84%
Holding current value
$1.97 Million
Previous $2.37 Million 15.82%
% of portfolio
0.19%
Previous 0.25%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $340,000 - $478,000
-200,000 Reduced 14.84%
1,147,500 $2 Million
Q1 2024

May 14, 2024

BUY
$1.66 - $2.42 $1.99 Million - $2.9 Million
1,200,000 Added 813.56%
1,347,500 $2.55 Million
Q4 2023

Feb 09, 2024

SELL
$1.25 - $2.35 $4.19 Million - $7.87 Million
-3,349,907 Reduced 95.78%
147,500 $318,000
Q3 2023

Nov 08, 2023

BUY
$1.5 - $3.07 $4.66 Million - $9.53 Million
3,104,062 Added 789.14%
3,497,407 $5.67 Million
Q2 2023

Aug 08, 2023

BUY
$1.79 - $2.9 $173,370 - $280,879
96,855 Added 32.67%
393,345 $967,000
Q1 2023

May 10, 2023

SELL
$2.65 - $3.81 $602,411 - $866,108
-227,325 Reduced 43.4%
296,490 $880,000
Q4 2022

Feb 03, 2023

BUY
$3.38 - $4.22 $813,312 - $1.02 Million
240,625 Added 84.97%
523,815 $1.91 Million
Q3 2022

Oct 28, 2022

SELL
$3.43 - $5.83 $814,710 - $1.38 Million
-237,525 Reduced 45.62%
283,190 $1.02 Million
Q2 2022

Jul 26, 2022

BUY
$4.41 - $5.69 $9,702 - $12,518
2,200 Added 0.42%
520,715 $1.5 Million
Q1 2022

May 09, 2022

BUY
$4.81 - $6.99 $1.07 Million - $1.56 Million
222,725 Added 75.3%
518,515 $1.54 Million
Q4 2021

Jan 25, 2022

SELL
$5.97 - $7.93 $16,119 - $21,411
-2,700 Reduced 0.9%
295,790 $2.01 Million
Q3 2021

Nov 03, 2021

BUY
$4.79 - $6.68 $12,933 - $18,036
2,700 Added 0.91%
298,490 $1.82 Million
Q2 2021

Jul 26, 2021

SELL
$5.35 - $6.35 $19,795 - $23,495
-3,700 Reduced 1.24%
295,790 $1.75 Million
Q1 2021

May 10, 2021

SELL
$5.68 - $7.87 $1.97 Million - $2.73 Million
-347,500 Reduced 53.71%
299,490 $1.8 Million
Q4 2020

Feb 10, 2021

BUY
$5.25 - $8.56 $822,517 - $1.34 Million
156,670 Added 31.95%
646,990 $4.48 Million
Q3 2020

Nov 12, 2020

BUY
$5.78 - $7.47 $49,939 - $64,540
8,640 Added 1.79%
490,320 $3.07 Million
Q2 2020

Aug 04, 2020

BUY
$4.5 - $7.02 $531,000 - $828,360
118,000 Added 32.45%
481,680 $3.18 Million
Q1 2020

Apr 29, 2020

BUY
$2.87 - $5.49 $387,929 - $742,066
135,167 Added 59.15%
363,680 $1.69 Million
Q4 2019

Feb 06, 2020

SELL
$3.84 - $4.86 $27,072 - $34,263
-7,050 Reduced 2.99%
228,513 $964,000
Q3 2019

Oct 25, 2019

SELL
$4.86 - $6.05 $7.12 Million - $8.86 Million
-1,464,470 Reduced 86.14%
235,563 $1.21 Million
Q1 2019

May 14, 2019

SELL
$5.16 - $6.85 $8.69 Million - $11.5 Million
-1,684,384 Reduced 49.77%
1,700,033 $10.6 Million
Q4 2018

Feb 13, 2019

BUY
$4.89 - $7.16 $16.5 Million - $24.2 Million
3,384,417 New
3,384,417 $16 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $305M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Sepio Capital, LP Portfolio

Follow Sepio Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.